FI960149L - Kumariinien ja karbostyriilien käyttö PLA2:n estäjinä, uusia kumariineja ja karbostyriilejä, menetelmä niiden valmistamiseksi ja lääkkeitä - Google Patents
Kumariinien ja karbostyriilien käyttö PLA2:n estäjinä, uusia kumariineja ja karbostyriilejä, menetelmä niiden valmistamiseksi ja lääkkeitä Download PDFInfo
- Publication number
- FI960149L FI960149L FI960149A FI960149A FI960149L FI 960149 L FI960149 L FI 960149L FI 960149 A FI960149 A FI 960149A FI 960149 A FI960149 A FI 960149A FI 960149 L FI960149 L FI 960149L
- Authority
- FI
- Finland
- Prior art keywords
- carbostyrils
- coumarins
- pharmaceuticals
- preparation
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Quinoline Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4323409A DE4323409A1 (de) | 1993-07-13 | 1993-07-13 | Verwendung von Cumarinen und Carbostyrilen als PLA¶2¶-Inhibitoren, neue Cumarine und Carbostyrile, Verfahren zu ihrer Herstellung und Arzneimittel |
| PCT/EP1994/002251 WO1995002588A1 (de) | 1993-07-13 | 1994-07-09 | Verwendung von cumarinen und carbostyrilen als pla2-inhibitoren, neue cumarine und carbostyrile, verfahren zu ihrer herstellung und arzneimittel |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI960149A0 FI960149A0 (fi) | 1996-01-12 |
| FI960149A7 FI960149A7 (fi) | 1996-01-12 |
| FI960149L true FI960149L (fi) | 1996-01-12 |
Family
ID=6492685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI960149A FI960149L (fi) | 1993-07-13 | 1994-07-09 | Kumariinien ja karbostyriilien käyttö PLA2:n estäjinä, uusia kumariineja ja karbostyriilejä, menetelmä niiden valmistamiseksi ja lääkkeitä |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5716983A (cs) |
| EP (1) | EP0708766B1 (cs) |
| JP (1) | JPH08512057A (cs) |
| KR (1) | KR960703887A (cs) |
| CN (1) | CN1130381A (cs) |
| AT (1) | ATE161010T1 (cs) |
| AU (1) | AU686197B2 (cs) |
| CA (1) | CA2167071A1 (cs) |
| CZ (1) | CZ6896A3 (cs) |
| DE (2) | DE4323409A1 (cs) |
| FI (1) | FI960149L (cs) |
| HU (1) | HUT73764A (cs) |
| NO (1) | NO960148L (cs) |
| NZ (1) | NZ268608A (cs) |
| RU (1) | RU2133745C1 (cs) |
| WO (1) | WO1995002588A1 (cs) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2301586A1 (en) * | 1997-08-28 | 1999-03-04 | William Louis Macias | Method for treatment of non-rheumatoid arthritis |
| TR200003194T2 (tr) | 1998-05-01 | 2001-03-21 | Eli Lilly And Company | Hastalık tedavisine mahsus sPLA2 önleyici bileşikler |
| JP2002533456A (ja) * | 1998-12-30 | 2002-10-08 | シグナル ファーマシューティカルズ， インコーポレイテッド | エストロゲン受容体のモジュレートを行うための化合物および方法 |
| US6291456B1 (en) | 1998-12-30 | 2001-09-18 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| US6331562B1 (en) | 1998-12-30 | 2001-12-18 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| GB9920912D0 (en) * | 1999-09-03 | 1999-11-10 | Indena Spa | Novel derivatives of flavones,xanthones and coumarins |
| US7027092B2 (en) * | 2001-09-17 | 2006-04-11 | Hewlett-Packard Development Company, L.P. | Image capture and storage device |
| AU2003230869B2 (en) * | 2002-04-26 | 2010-02-25 | Ortho-Mcneil Pharmaceutical, Inc. | 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| KR20040001144A (ko) * | 2002-06-27 | 2004-01-07 | 김대경 | 신규한 적혈구 세포질형 포스포리파아제 에이 투 효소,그에 대한 항체, 이들의 용도 및 제조 방법 |
| US7538233B2 (en) * | 2003-09-05 | 2009-05-26 | Aventis Pharmaceuticals Inc. | Coumarins as iNOS inhibitors |
| DE102004063910B4 (de) * | 2004-07-05 | 2006-12-28 | Bioplanta Arzneimittel Gmbh | Trisubstituierte Benzopyranone sowie diese enthaltende Pflanzenextrakte und Mittel |
| CN102532015B (zh) * | 2012-01-18 | 2013-10-23 | 云南大学 | 香豆素及其类似物的固相合成方法 |
| CN105687184A (zh) * | 2016-04-06 | 2016-06-22 | 梁海月 | 蛇床子素在制备治疗溃疡性结肠炎的药物方面的应用 |
| CN111423450B (zh) * | 2020-04-29 | 2021-10-26 | 上海天马有机发光显示技术有限公司 | 化合物、显示面板以及显示装置 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU175622A (cs) * | ||||
| FR2035M (fr) * | 1962-06-29 | 1963-09-23 | Dausse Lab | Médicament a base de dérivé du méthyl-4 esculétol. |
| BE734121A (cs) * | 1968-06-14 | 1969-11-17 | ||
| GB1432809A (en) * | 1973-04-19 | 1976-04-22 | Beecham Group Ltd | Coumarin derivatives |
| FR2276819A1 (fr) * | 1974-07-05 | 1976-01-30 | Fabre Sa Pierre | Facteurs p lipophile a action anti-inflammatoire locale utilisables dans le traitement de syndromes dermatologiques |
| US4136192A (en) * | 1975-09-23 | 1979-01-23 | Beecham Group Limited | 4-hydroxy-3-nitro (cyano) coumarins |
| US4210667A (en) * | 1979-04-19 | 1980-07-01 | Pfizer Inc. | Pharmaceutical preparations containing coumarin carboxylic acid derivatives |
| JPS6056985A (ja) * | 1983-09-08 | 1985-04-02 | Sankyo Co Ltd | クマリン誘導体 |
| DE3568773D1 (en) * | 1984-05-24 | 1989-04-20 | Ciba Geigy Ag | Resorcin ethers |
| IT1196133B (it) * | 1984-06-06 | 1988-11-10 | Ausonia Farma Srl | Derivati furanici con attivita' antiulcera |
| DE3427985A1 (de) * | 1984-07-28 | 1986-01-30 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue 2h-l-benzopyran-2-on-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten |
| US5124334A (en) * | 1987-11-30 | 1992-06-23 | Du Pont Merck Pharmaceutical Company | Benzylalcohol phospholipase A2 inhibitors |
| FR2677023B1 (fr) * | 1991-05-30 | 1994-02-25 | Eurobio Laboratoires | Derives de coumarine hydrosolubles, leur preparation et leur utilisation comme substrat d'enzyme. |
| JPH06312925A (ja) * | 1993-03-02 | 1994-11-08 | Kureha Chem Ind Co Ltd | 軟骨保護剤及び新規エスクレチン誘導体 |
| AU674779B2 (en) * | 1993-10-01 | 1997-01-09 | Shionogi & Co., Ltd. | Novel carboxylate derivatives exhibiting phospholipase A2 inhibitory activity |
-
1993
- 1993-07-13 DE DE4323409A patent/DE4323409A1/de not_active Withdrawn
-
1994
- 1994-07-09 CZ CZ9668A patent/CZ6896A3/cs unknown
- 1994-07-09 AT AT94920981T patent/ATE161010T1/de not_active IP Right Cessation
- 1994-07-09 CA CA002167071A patent/CA2167071A1/en not_active Abandoned
- 1994-07-09 KR KR1019960700230A patent/KR960703887A/ko not_active Ceased
- 1994-07-09 JP JP7503693A patent/JPH08512057A/ja active Pending
- 1994-07-09 CN CN94193250A patent/CN1130381A/zh active Pending
- 1994-07-09 US US08/569,197 patent/US5716983A/en not_active Expired - Fee Related
- 1994-07-09 EP EP94920981A patent/EP0708766B1/de not_active Expired - Lifetime
- 1994-07-09 AU AU71880/94A patent/AU686197B2/en not_active Ceased
- 1994-07-09 NZ NZ268608A patent/NZ268608A/en unknown
- 1994-07-09 WO PCT/EP1994/002251 patent/WO1995002588A1/de not_active Ceased
- 1994-07-09 DE DE59404786T patent/DE59404786D1/de not_active Expired - Fee Related
- 1994-07-09 FI FI960149A patent/FI960149L/fi unknown
- 1994-07-09 RU RU96102842A patent/RU2133745C1/ru active
- 1994-07-09 HU HU9503973A patent/HUT73764A/hu unknown
-
1996
- 1996-01-12 NO NO960148A patent/NO960148L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH08512057A (ja) | 1996-12-17 |
| FI960149A0 (fi) | 1996-01-12 |
| RU2133745C1 (ru) | 1999-07-27 |
| WO1995002588A1 (de) | 1995-01-26 |
| ATE161010T1 (de) | 1997-12-15 |
| US5716983A (en) | 1998-02-10 |
| NO960148D0 (no) | 1996-01-12 |
| EP0708766A1 (de) | 1996-05-01 |
| DE59404786D1 (de) | 1998-01-22 |
| CZ6896A3 (en) | 1996-04-17 |
| DE4323409A1 (de) | 1995-01-19 |
| CA2167071A1 (en) | 1995-01-26 |
| KR960703887A (ko) | 1996-08-31 |
| AU686197B2 (en) | 1998-02-05 |
| NZ268608A (en) | 1997-09-22 |
| AU7188094A (en) | 1995-02-13 |
| HU9503973D0 (en) | 1996-03-28 |
| EP0708766B1 (de) | 1997-12-10 |
| FI960149A7 (fi) | 1996-01-12 |
| CN1130381A (zh) | 1996-09-04 |
| HUT73764A (en) | 1996-09-30 |
| NO960148L (no) | 1996-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI942074A7 (fi) | nor-sappijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina | |
| NO973479L (no) | Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme | |
| FI952230L (fi) | Uusi aryylipropaanijohdannainen, menetelmä sen valmistamiseksi ja sen käyttö analgeettisena aineena | |
| FI954246L (fi) | Uusia A83543-yhdisteitä ja menetelmä niiden valmistamiseksi | |
| FI942076L (fi) | Sappihappojohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkaaineina | |
| FI962599A7 (fi) | Enantioselektiivinen menetelmä kiraalisten triaryylijohdannaisten ja n iiden valmistuksessa käytettävien kiraalisten välituotteiden valmistam iseksi | |
| FI953467A7 (fi) | Aminohappojohdannaisia, näitä yhdisteitä sisältävät lääkeaineet ja men etelmä niiden valmistamiseksi | |
| FI956341L (fi) | Metyylifosfonihappoesteri, menetelmä sen valmistamiseksi ja sen käyttö | |
| FI954304A7 (fi) | Uudet bentsopyraanijohdannaiset, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| FI956080L (fi) | Kuidutettu selluloosatuote ja menetelmä sen valmistamiseksi | |
| FI952014L (fi) | Uusia bisyklisiä merkaptoasetyyliamidilaktaamijohdannaisia, jotka ovat hyödyllisiä enkefalinaasin ja ACE:n inhibiittoreina | |
| FI905171A7 (fi) | Kinoloniyhdisteet ja menetelmä niiden valmistamiseksi | |
| FI930326L (fi) | Pinnoiteseos ja menetelmä sen valmistamiseksi | |
| FI953919A7 (fi) | Pyrrolydeenimetyylijohdannaiset ja menetelmä niiden valmistamiseksi | |
| FI960149A7 (fi) | Kumariinien ja karbostyriilien käyttö PLA2:n estäjinä, uusia kumariine ja ja karbostyriilejä, menetelmä niiden valmistamiseksi ja lääkkeitä | |
| FI952550A7 (fi) | Uudet N-pyridyylikarboksamidit ja johdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| FI951387L (fi) | Sulfonamidokarbonyylipyridiini-2-karboksyylihappoesteriamidit sekä niiden pyridiini-N-oksidit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| FI902248A7 (fi) | N-heteroaryyli-4-kinoliiniamiineja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| FI943688L (fi) | Uudet 11-bentsaldoksiimi-17beta-metoksi-27alfa-metoksi-metyyli-estradieenijohdannaiset, menetelmät niiden valmistamiseksi ja näitä sisältävät lääkeaineet | |
| FI922875A7 (fi) | Reniiniä estävät yhdisteet, menetelmä niiden valmistamiseksi ja niidenkäyttö | |
| FI941836A7 (fi) | 3-deoksioligosakkaridit, menetelmiä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| FI902850A7 (fi) | N-heteroaryylipuriini-6-amiineja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineina | |
| FI952324L (fi) | Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet | |
| FI953384L (fi) | Uusi bentsolitiaditsiiniyhdiste, menetelmä sen valmistamiseksi ja sitä sisältävät farmaseuttiset koostumukset | |
| FI951631L (fi) | Substituoituja kynureniinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Name/ company changed in application |
Owner name: ROCHE DIAGNOSTICS GMBH |